Lutherville-Timonium, MD, United States of America

Ying Chen

This inventor holds 17 USPTO granted patents and 13 published patent applications and 8 EPO patents. Top assignees: Johns Hopkins University, Northwestern University. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Chen. Retrieved from https://idiyas.com/inventor/ying-chen-niuceqqq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 13)

% Patents Active = 100.0

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 203(Granted Patents)

Location History:

Timmonium, MD (US) (2016 - 2020)
Timonium, MD (US) (2014 - 2024)
Lutherville-Timonium, MD (US) (2018 - 2024)

Company Filing History:

17 out of 3,801

Johns Hopkins University

patents

1 out of 2,217

Northwestern University

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12070513 - PSMA-binding agents and uses thereof (2024-08-27),

2. 12065413 - PSMA targeted fluorescent agents for image guided surgery (2024-08-20),

3. 11911488 - Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy (2024-02-27),

4. 11851407 - Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [F]DCFPYL (2023-12-26),

5. 11814365 - PSMA targeted fluorescent agents for image guided surgery (2023-11-14),

6. 11661402 - PSMA-targeting compounds and uses thereof (2023-05-30),

7. 11078166 - Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof (2021-08-03),

8. 11021450 - PSMA targeted fluorescent agents for image guided surgery (2021-06-01),

9. 10947197 - Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [F]DCFPyL (2021-03-16),

10. 10736974 - Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy (2020-08-11),

11. 10683272 - Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy (2020-06-16),

12. 10500292 - PSMA-binding agents and uses thereof (2019-12-10),

13. 10232058 - Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy (2019-03-19),

14. 9861713 - PSMA-binding agents and uses thereof (2018-01-09),

15. 9226981 - PSMA-binding agents and uses thereof (2016-01-05),

Title: The Innovative Journey of Ying Chen

Introduction: Ying Chen, a talented inventor hailing from Lutherville-Timonium, MD (US), has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Ying Chen's most recent patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a novel medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: With a background in electrical engineering, Ying Chen has spent over two decades honing his skills in innovation. He has worked for several leading tech companies, where he has spearheaded projects that have garnered international acclaim.

Collaborations: Throughout his career, Ying Chen has collaborated with top researchers, engineers, and designers to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Ying Chen's passion for innovation, coupled with his technical expertise, has solidified his reputation as a visionary inventor. His relentless pursuit of excellence continues to drive him towards creating solutions that have a lasting impact on society.

Profile summary based on public USPTO records.